Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-08
1996-12-17
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514557, 546335, 562441, 562442, 562443, 562444, 562451, 562505, 562506, 562507, 562567, 562575, A61K 3144, C07D21302
Patent
active
055853919
ABSTRACT:
The invention concerns the discovery of the surprising and unexpected therapeutic effects of hydroxyl ions. The observed medicinal properties of these ions are both novel and broad in scope. The acute corrosive effects and toxicity of hydroxyl ions on living tissue has previously overwhelmed their therapeutic attributes. Unique hydroxyl ion modulating compounds have been discovered and are within the scope of the invention. When used appropriately as companions with hydroxyl ions, these modulating compounds obviate and attenuate the harmful effects of hydroxyl ions, unmasking and revealing their previously unknown and undemonstratable therapeutic properties. These hydroxyl ion modulating compounds do not significantly interfere with the surprising and unexpected therapeutic benefits of the hydroxyl ions. The novel hydroxyl ion modulating compounds are generally characterized as N,N-disubstituted-aminoacetate salts and substituted N,N-substituted-aminoacetate salts. The invention includes compositions and methods of treatment using hydroxyl ions and the companion hydroxyl ion modulating compounds. These compositions and methods of treatment provide a wide variety of therapeutic effects including dermal effects (such as wound healing), ocular effects, oral therapeutic effects, ear, nose and throat therapeutic effects and internal therapeutic effects.
REFERENCES:
patent: 3075924 (1963-01-01), Rubin
patent: 3151084 (1964-09-01), Schiltz
patent: 3492238 (1970-01-01), Wohlberg
patent: 3920020 (1975-11-01), Kraskin
patent: 3932607 (1976-01-01), Hesselgren
patent: 3935862 (1976-02-01), Kraskin
patent: 3965048 (1976-06-01), Murtaugh
patent: 3975313 (1976-08-01), Shelmire, Jr.
patent: 4107331 (1978-08-01), Rosenberg
patent: 4337269 (1982-06-01), Berke et al.
patent: 4528370 (1985-07-01), Lai
patent: 4584121 (1986-04-01), Blaschke et al.
patent: 4767786 (1988-08-01), Farrish
patent: 4847083 (1989-07-01), Clark
patent: 4868213 (1989-09-01), Farrish
patent: 4915864 (1990-04-01), Kita et al.
patent: 5015409 (1991-05-01), Read, Jr. et al.
Farfan, Synthesis, vol. 10, pp. 927-929, 1987.
Giraud-Clenet et al, C. R. Acad. Sci., Paris, Ser. C, vol. 268, No. 1, pp. 117-120, 1969.
Material Safety Data, Jan. 10, 1990, W. R. Grace & Co., Organic Chemicals Division, 55 Hayden Avenue, Lexington, MA, USA 02173.
Technical Information, Jan. 8, 1976; Hampshire, Organic Chemicals Division, W. R. Grace & Co., 55 Hayden Avenue, Lexington, MA 01273.
Carrell Delton R.
Cragoe, Jr. Edward J.
Davis Zinna N.
FHJ Scientific, Inc.
Ivy C. Warren
Uxa Frank J.
LandOfFree
Hydroxyl ions as unique therapeutic agents and compounds that mo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxyl ions as unique therapeutic agents and compounds that mo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxyl ions as unique therapeutic agents and compounds that mo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991574